TheEdgeResearch
Home / Stocks / MDGS

Xylo Technologies Ltd. (MDGS)

NASDAQ Healthcare Medical - Devices
$2.36 ▲ +10.28%
Market Cap
$178.9M
Sector
Healthcare
Industry
Medical - Devices
Beta
1.37
52-Wk Range
1.5396-7.17
CEO
Liron Carmel
Country
IL
Currency
USD

Xylo Technologies Ltd. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Tel Aviv, IL. The stock last traded at $2.36, up 10.28% on the session, giving a market capitalisation of $178.9M. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -17.5%. Its beta of 1.37 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
1.95
Price / Book
0.00
EV / EBITDA
-6.57
Gross margin
12.9%
Operating margin
-25.4%
Net margin
-17.5%
Return on equity
Debt / equity
0.42
Current ratio
1.08
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
38
IPO date
2015-08-05
Headquarters
Tel Aviv, IL
About Xylo Technologies Ltd.

Xylo Technologies Ltd. operates as a technology-focused enterprise, providing a comprehensive range of medical devices and related products to international markets, encompassing the United States, Europe, Asia, and Israel. The company's diverse operations are organized into several distinct segments, including Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and other divisions. Among its medical innovations is the Medigus Ultrasonic Surgical Endostapler, an advanced endoscopy system specifically utilized for treating gastroesophageal reflux disease. Xylo Technologies also develops specialized biological gels, engineered to safeguard patients against biological threats and to minimize the intrusion of allergens and viruses through the upper respiratory passages and ocular areas. Beyond its healthcare offerings, the company maintains a significant presence in the digital sector. This includes furnishing a digital advertising platform, managing various online retail outlets for consumer products on the Amazon marketplace, and operating an online platform for event management and ticketing services. Furthermore, Xylo Technologies is actively engaged in pioneering wireless battery charging technologies for vehicles and developing modular electronic vehicles. The organization, which was previously known as Medigus Ltd., officially adopted its current name, Xylo Technologies Ltd., in April 2024. Established in 1999, the company maintains its corporate headquarters in Tel Aviv-Yafo, Israel.

Comparable companies

Xylo Technologies Ltd. is most often compared with the following Healthcare names:

APTOGMDAHILSMNKNBRVFNUVOPEARRMEDTNFAVRAY
More research on MDGS
MDGS technical analysis MDGS TheEdge Score Compare against peers
Open full interactive analysis & DCF →